Onizuka Makoto

Research theme for competitive and other funds (4)：

2018 - 2021 An analysis for development of myelodysplastic syndrome and influence of ROS
2017 - 2020 Elucidation of the taste disorders using gene expression analysis
2016 - 2018 An analysis of HLA-LOH in relapsed tumor by using NGS after allogeneic stem cell transplantation
2012 - 2015 Renin-angiotensin system and non-infectious pulmonary complication after stem cell transplantation

Papers (275)：

Masaharu Tamaki, Shunto Kawamura, Kosuke Takano, Hirohisa Nakamae, Noriko Doki, Hiroyuki Ohigashi, Yumiko Maruyama, Shuichi Ota, Nobuhiro Hiramoto, Tetsuya Eto, et al. Female-to-male allogeneic transplantation affects outcomes differently according to the type of haplo-transplantation. Cytotherapy. 2024
Masaharu Tamaki, Yu Akahoshi, Yoshihiro Inamoto, Kaoru Morita, Naoyuki Uchida, Noriko Doki, Masatsugu Tanaka, Tetsuya Nishida, Hiroyuki Ohigashi, Hirohisa Nakamae, et al. Associations between acute and chronic graft-versus-host disease. Blood advances. 2024. 8. 16. 4250-4261
Yukinori Nakamura, Yoshitaka Zaimoku, Hiroki Yamaguchi, Hirohito Yamazaki, Minoru Kanaya, Naoyuki Uchida, Noriko Doki, Masatoshi Sakurai, Nobuhiro Hiramoto, Shinichi Kako, et al. Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia. Annals of hematology. 2024. 103. 8. 3121-3133
Kentaro Ido, Hirohisa Nakamae, Norimichi Hattori, Minoru Kanaya, Kaoru Morita, Masayuki Hino, Hiroyuki Ohigashi, Takahiro Fukuda, Tetsuya Eto, Koji Nagafuji, et al. Effect of peptide-binding motif on survival of HLA-haploidentical transplantation with post-transplant cyclophosphamide. British journal of haematology. 2024
Takanori Teshima, Yasushi Onishi, Koji Kato, Shuichi Taniguchi, Koichi Miyamura, Kentaro Fukushima, Jun Kato, Takayuki Ishikawa, Noriko Doki, Hirohisa Nakamae, et al. Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial. International journal of hematology. 2024. 120. 1. 106-116

ｍore...

MISC (52)：

小沼貴晶, 糸永英弘, 石山謙, 土岐典子, 内田直之, 小澤幸泰, 片山雄太, 片岡圭亮, 上田恭典, 松岡賢市, et al. Trends of allogeneic transplant outcomes for adult myelodysplastic syndrome in Japan. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
黒澤修兵, 下村良充, 下村良充, 糸永英弘, 片山雄太, 鬼塚真仁, 田中正嗣, 小林光, 小澤幸泰, 澤正史, et al. Impact of melphalan dose in patients with MDS undergoing allo-HSCT with RIC. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 45th
水野昌平, 高見昭良, 河村浩二, 下村良充, 新井康之, 小沼貴晶, 小澤幸泰, 澤正史, 太田秀一, 高橋聡, et al. Comparison of Flu/Bu4/Mel with TBI-based MAC in AML patients with complete remission undergoing CBT. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
松田健佑, 小沼貴晶, 布施香子, 増子正義, 河村浩二, 平山雅浩, 内田直之, 池亀和博, 和氣敦, 衛藤徹也, et al. Haploidentical transplantation versus cord blood transplantation for AML in non-remission. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2022. 44th
Yoshimitsu Shimomura, Tomotaka Sobue, Shigeki Hirabayashi, Tadakazu Kondo, Shohei Mizuno, Junya Kanda, Takahiro Fujino, Keisuke Kataoka, Naoyuki Uchida, Tetsuya Eto, et al. Comparing Single Cord Blood Transplantation and Matched Related Donor Transplantation in Non-Remission Acute Myeloid Leukemia. BLOOD. 2021. 138. 1790-+

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page